Work with your personal adviser to grow your wealth

Scottish Mortgage Trust – Investment Update


Biotech stake spikes tenfold as SPAC listing looms

One of Scottish Mortgage’s portfolio holding that has already offered a tenfold return on capital, is poised to offer a chunky exit as it merges with a special-purpose acquisition company (SPAC). Ginkgo Bioworks, an off-market business that engineers micro-organisms for industrial use, will enter trading in September via a merger with Soaring Eagle Acquisition Corporation, a SPAC launched by former Hollywood executive Harry Sloan.

The deal, which will bring in $2.5bn (£1.82bn) in new capital, values the business at around $17.5bn, making it one of the largest SPAC listings ever. Scottish Mortgage has invested a total of around £44m into just over a million shares in the MIT spin-off since an initial purchase in 2016. Those were valued at around £164m in March, but near trebled between then and June after Ginkgo announced the SPAC merger. The stake is now worth around £450m, 10 times the Company’s original investment.

Related Posts

Is it Time to Rethink your Term Deposit Strategy?

Term deposits are currently riding near a 15-year peak, offering investors a temporary high. However, this…


Dovish sentiment favours accommodative policies, aiming to stimulate economic growth even at the cost of higher…

International Women’s Day

International Women’s Day provides an important opportunity to fundraise for female-focused charities, help raise their visibility,…

Investing for Income

Tom McBride and Richard Parkin hosted an investor seminar at the Novotel Cathedral Christchurch on Thursday…